Zhou Han

Zhou Han

Auto-generated profile, based on publicly available information

Zhou Han

Stoke Therapeutics Inc., Bedford, MA 01730, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
ZHZhou Han
Zhou Han
CCChunling Chen
Chunling Chen
ACAnne Christiansen
Anne Christiansen
SJSophina Ji
Sophina Ji
QLQian Lin
Qian Lin
LILori L. Isom
Lori L. Isom
Antisense oligonucleotide administration reduces seizures and SUDEP incidence in a mouse model of Dravet syndrome.

9 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
KLKian Huat Lim
Kian Huat Lim
ZHZhou Han
Zhou Han
HJHyun Yong Jeon
Hyun Yong Jeon
JKJacob Kach
Jacob Kach
EJEnxuan Jing
Enxuan Jing
IAIsabel Aznarez
Isabel Aznarez
While most monogenic diseases are caused by loss or reduction of protein function, the need for technologies that can selectively increase levels of protein in native tissues remains. Here we demonstrate that antisense-mediated modulation of pre-mRNA splicing can increase endogenous expression of full-length protein by preventing naturally occurring non-productive alternative splicing and promoting generation of productive mRNA. Bioinformatics analysis of RNA sequencing data identifies non-productive splicing events in 7,757 protein-coding human genes, of which 1,246 are disease-associated. Antisense oligonucleotides targeting multiple types of non-productive splicing events lead to increases in productive mRNA and protein in a dose-dependent manner in vitro. Moreover, intracerebroventricular injection of two antisense oligonucleotides in wild-type mice leads to a dose-dependent increase in productive mRNA and protein in the brain. The targeting of natural non-productive alternative splicing to upregulate expression from wild-type or hypomorphic alleles provides a unique approach to treating genetic diseases.